At Rhythm Express, we’re committed to pushing the boundaries of cardiac monitoring technology. Our Clinical Evidence Library showcases the scientific foundation of our innovative solutions, featuring peer-reviewed papers, fact sheets, and comprehensive guides that demonstrate the efficacy and reliability of our RX-1 mini device. Explore our collection of resources to stay informed about the latest developments in cardiac monitoring and Rhythm Express innovations.
MINNEAPOLIS–(BUSINESS WIRE)–VivaQuant®, Inc. d.b.a. Rhythm Express® has been named to the 2026 Inc. 5000, the most prestigious ranking of America’s fastest growing private companies. The recognition highlights the company’s continued innovation in remote cardiac monitoring and digital health.
Most cardiologists treating atrial fibrillation are already screening for the usual suspects: hypertension, heart failure, diabetes, coronary artery disease. But
When a cardiologist selects a remote cardiac monitoring vendor, clinical performance is the obvious priority. Turnaround time, report quality, monitoring
